Overview
This study will conduct a single-center clinical trial to explore the initial therapeutic effect of ginkgo biloba dropping pills, huperzine A injection and median nerve electrical stimulation in patients with cognitive impairment.
Description
Specific experimental research methods were randomized, controlled, single-center, exploratory clinical study, through the treatment of ginkgo biloba dropping pills, huperzine A injection and median nerve electrical stimulation in patients with cognitive impairment, to observe the effects of their neuroprotection and cognitive function improvement.
Eligibility
Inclusion Criteria:
- Be over 18 years old
- Residual cognitive impairment due to brain injury
- No previous history of brain-related diseases except this one
- Residual cognitive impairment due to brain injury
Exclusion Criteria:
- The patient had severe underlying disease and unstable vital signs
- The patient was complicated with consciousness disorder and could not cooperate with cognitive function assessment ③ Allergic to drugs or contraindications in drug use ④ There are contraindications of median nerve electrical stimulation